Chlamydia pneumoniae Antibodies in Severe Essential Hypertension

Author:

Cook P. J.1,Lip G. Y. H.1,Davies P.1,Beevers D. G.1,Wise R.1,Honeybourne D.1

Affiliation:

1. From the Department of Thoracic Medicine (P.J.C., D.H.); the University Department of Medicine (G.Y.H.L., D.G.B.); and the Department of Microbiology (R.W.), City Hospital, Birmingham, and the School of Mathematics and Statistics, University of Birmingham (P.D.), United Kingdom.

Abstract

Abstract —Several studies have implied an association between Chlamydia pneumoniae (C. pneumoniae) and cardiovascular disease. Our study was designed to determine whether this organism is associated with severe essential hypertension in a multiracial British population. Antibodies to C. pneumoniae were measured by microimmunofluorescence in 123 patients with chronic severe hypertension and 123 control subjects, matched for ethnic origin, age, sex, and smoking habit, admitted to the same hospital with various noncardiovascular, nonpulmonary disorders. Previous infection was defined by IgG 64 to 256, provided that there was no detectable IgM. Multiple regression analyses of matched and unmatched data were used to investigate the influences of antibody levels and potential confounding factors (ethnic origin, age, sex, smoking habit, diabetes mellitus, and social deprivation) on hypertension. A portion of the hypertensive patients underwent echocardiography, estimation of left ventricular mass index, and measurements of fibrinogen, D-dimer, and von Willebrand factor concentrations. Thirty-five percent of hypertensive patients and 17.9% of matched control subjects had antibody titers consistent with previous C. pneumoniae infection. The hypertensive patients differed significantly from their matched control subjects in their level of previous infection, with an odds ratio of 2.5 (95% confidence interval, 1.3 to 4.7). There were no significant differences in antibody levels between patients with left ventricular hypertrophy and those without it. Fibrinogen, D-dimer, and von Willebrand factor concentrations were not significantly associated with antibody levels. These data support an association of C. pneumoniae with severe essential hypertension. They provide no evidence of a predisposition to develop left ventricular hypertrophy in hypertensive patients with C. pneumoniae infection or of associations with hypercoagulability or endothelial dysfunction.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference59 articles.

1. A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract Infections

2. Wang SP Grayston JT. Micro-immunofluorescence serological studies with the TWAR organism. In: Oriel JD Ridgway GL Schachter J Taylor-Robinson D Ward ME eds. Chlamydial Infections. Cambridge UK: Cambridge University Press; 1986:329–332.

3. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia

4. Prevalence of antibody to Chlamydia pneumoniae TWAR in japan

5. HIGH PREVALENCE OF CHLAMYDIA PNEUMONIAE INFECTION IN CHILDREN AND YOUNG ADULTS IN SPAIN

Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3